Your search returned 8 results.

Results
	1.	Anti-PD-L1 Treatment Induced Central Diabetes Insipidus. MedStar authors: Kommalapati, Anuhya PMID: 29220526 Year: 2018 Citation: Journal of Clinical Endocrinology & Metabolism. 103(2):365-369, 2018 02 01. Institution: MedStar Washington Hospital Center Department: Medicine/Internal Medcine Medline publication type: Journal Article Form of publication: Journal Article All authors: Brownell I, Del Rivero J, Ebenuwa I, Gulley J, Kommalapati A, Strauss J, Tella SH, Zhao C DOI: https://dx.doi.org/10.1210/jc.2017-01905 Add to cart (remove)
	2.	Prevalence and predictors of sustained remission/low disease activity after discontinuation of induction or maintenance treatment with tumor necrosis factor inhibitors in rheumatoid arthritis: a systematic and scoping review. MedStar authors: Constantinescu, Florina PMID: 37986101 Year: 2023 Citation: Arthritis Research & Therapy. 25(1):222, 2023 Nov 20. Institution: MedStar Washington Hospital Center Department: Rheumatology Medline publication type: Journal Article Systematic Review Form of publication: Journal Article All authors: Ward MM, Madanchi N, Yazdanyar A, Shah NR, Constantinescu F DOI: Click here to access online Add to cart (remove)
	3.	Normalized early post-operative cortisol and ACTH values predict nonremission after surgery for Cushing's disease. MedStar authors: Sharma, Susmeeta T PMID: 28323961 Year: 2017 Citation: Journal of Clinical Endocrinology & Metabolism. 102(7):2179-2187, 2017 Jul 01 Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Form of publication: Journal Article All authors: Asuzu D, Benzo S, Beri A, Chatain GP, Chittiboina P, Hayes C, Keil M, Lodish M, Lonser RR, McGlotten R, Nieman L, Oldfield EH, Sharma ST, Stratakis C DOI: https://dx.doi.org/10.1210/jc.2016-3908 Add to cart (remove)
	4.	Earlier post-operative hypocortisolemia may predict durable remission from Cushing's Disease. MedStar authors: Sharma, Susmeeta PMID: 29330227 Year: 2018 Citation: European Journal of Endocrinology. 178(3):255-263, 2018 Mar Institution: MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Form of publication: Journal Article All authors: Asuzu D, Benzo S, Chatain G, Chittiboina P, Ironside N, Lodish M, Lonser R, Nieman L, Sharma S, Stratakis C DOI: https://dx.doi.org/10.1530/EJE-17-0873 Add to cart (remove)
	5.	Treatment with metformin is associated with higher remission rate in diabetic patients with thyroid cancer. MedStar authors: Burman, Kenneth D Klubo-Gwiezdzinska, Joanna Mete, Mihriye Wartofsky, Leonard PMID: 23709654 Citation: Journal of Clinical Endocrinology & Metabolism. 98(8):3269-79, 2013 Aug. Institution: MedStar Health Research Institute MedStar Washington Hospital Center Department: Medicine/Endocrinology Medline publication type: Journal Article Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Bauer A, Burman KD, Costello J Jr, Jensen K, Klubo-Gwiezdzinska J, Mete M, Patel A, Vasko V, Wartofsky L DOI: http://dx.doi.org/10.1210/jc.2012-3799 Add to cart (remove)
	6.	A phase 1 study of lenalidomide and ibrutinib in combination with rituximab in relapsed and refractory CLL. MedStar authors: Trivedi, Neel PMID: 29610115 Year: 2018 Citation: Blood Advances. 2(7):762-768, 2018 Apr 10 Institution: MedStar Washington Hospital Center Department: Hematology and Oncology Medline publication type: Journal Article Form of publication: Journal Article All authors: Cheson BD, Khan N, Ramzi P, Skarbnik A, Trivedi N, Ujjani C, Wang H DOI: https://dx.doi.org/10.1182/bloodadvances.2017015263 Add to cart (remove)
	7.	Regression from prediabetes to normal glucose regulation is associated with reduction in cardiovascular risk: results from the Diabetes Prevention Program outcomes study. MedStar authors: Thayer, Debra W PMID: 24969574 Year: 2014 Citation: Diabetes Care. 37(9):2622-31, 2014 Sep. Form of publication: Journal Article All authors: Diabetes Prevention Program Research Group, Goldberg RB, Hamman RF, Horton E, Kitabchi A, Larkin M, Mather KJ, Montez MG, Orchard TJ, Perreault L, Temprosa M, Thayer D DOI: http://dx.doi.org/10.2337/dc14-0656 Add to cart (remove)
	8.	Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial. MedStar authors: Kumar, Anjali S PMID: 26187751 Citation: Lancet Oncology. 16(8):957-66, 2015 Aug. Institution: MedStar Washington Hospital Center Department: Surgery/Colorectal Surgery Medline publication type: Clinical Trial, Phase II Journal Article Multicenter Study Research Support, N.I.H., Extramural Form of publication: Journal Article All authors: Avila K, Cataldo PA, Chow OS, Coutsoftides T, Dietz DW, Fichera A, Garcia-Aguilar J, Herzig DO, Hunt SR, Kumar AS, Marcet JE, Oommen S, Patil S, Polite BN, Smith DD, Stamos MJ, Ternent CA, Timing of Rectal Cancer Response to Chemoradiation Consortium, Varma MG DOI: http://dx.doi.org/10.1016/S1470-2045(15)00004-2 Add to cart (remove)

Powered by Koha